{
    "clinical_study": {
        "@rank": "156390", 
        "arm_group": {
            "arm_group_label": "RoActemra/Actemra", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This open-label, multicenter study will evaluate the pharmacokinetics, pharmacodynamics and\n      safety of subcutaneously administered RoActemra/Actemra (tocilizumab) in patients with\n      systemic juvenile idiopathic arthritis. Patients will receive RoActemra/Actemra\n      subcutaneously weekly or every 10 days for 52 weeks."
        }, 
        "brief_title": "A Study of Subcutaneously Administered RoActemra/Actemra (Tocilizumab) in Patients With Systemic Juvenile Idiopathic Arthritis", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Juvenile Idiopathic Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Juvenile Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ages 1 year up to and including 17 years at screening\n\n          -  Diagnosis of sJIA according to the ILAR classification (Petty et al. 2004)\n\n          -  History of inadequate clinical response (in the opinion of the treating physician) to\n             NSAIDs and corticosteroids\n\n          -  If a patient has received previous treatment with any biologic agents other than TCZ\n             (tocilizumab), these must have been discontinued according to the timelines defined\n             by protocol prior to the baseline visit\n\n          -  Patients currently receiving TCZ by the IV route of administration and with\n             well-controlled disease do not require a period of discontinuation of IV TCZ and\n             should have their first dose of SC TCZ administered on the date that their next IV\n             TCZ infusion would be due\n\n          -  Concurrent treatment with DMARDs (including MTX), NSAIDs, and oral corticosteroids\n             are permitted at the discretion of the investigator\n\n          -  Females of childbearing potential and non-sterile males with female partner of\n             childbearing potential must agree to use effective contraception as defined by\n             protocol\n\n        Exclusion Criteria:\n\n          -  Prior discontinuation of IV TCZ because of inadequate clinical response or safety\n             events (including hypersensitivity)\n\n          -  Patients with poorly controlled disease (in the opinion of the treating physician)\n             despite current treatment with IV TCZ\n\n          -  sJIA that is well controlled by any treatment agent other than TCZ (Juvenile\n             Arthritis Disease Activity Score [JADAS]-71 </= 3.8 with no fever)\n\n          -  Patients who are wheelchair-bound or bedridden\n\n          -  Any other auto-immune, rheumatic disease, or overlapping syndrome other than sJIA\n\n          -  Lack of recovery from recent surgery or an interval of < 6 weeks since surgery at the\n             time of the screening visit\n\n          -  Females who are pregnant, lactating, or intending to become pregnant during study\n             conduct\n\n          -  Any significant concurrent medical or surgical condition that would jeopardize the\n             patient's safety or ability to complete the study\n\n          -  Known HIV infection or other acquired forms of immune compromise or inborn conditions\n             characterized by a compromised immune system\n\n          -  History of alcohol, drug, or chemical abuse within 6 months of screening\n\n          -  Any active acute, subacute, chronic, or recurrent bacterial, viral, or systemic\n             fungal infection or any major episode of infection requiring hospitalization or\n             treatment during screening or treatment with IV antibiotics completed within 4 weeks\n             of the screening visit or oral antibiotics completed within 2 weeks of the screening\n             visit\n\n          -  History of atypical tuberculosis (TB) or active TB requiring treatment within 2 years\n             prior to screening visit\n\n          -  Positive TB test at screening unless treated with anti-TB therapy for at least 4\n             weeks prior to receiving study drug\n\n          -  History of reactivation or new onset of a systemic infection such as herpes zoster or\n             Epstein-Barr virus within 2 months of the screening visit\n\n          -  Hepatitis B surface antigen or hepatitis C antibody positivity or chronic viral or\n             autoimmune hepatitis\n\n          -  History of concurrent serious gastrointestinal disorders such as ulcer or\n             inflammatory bowel disease, Crohn's disease, ulcerative colitis, or other symptomatic\n             lower gastrointestinal conditions\n\n          -  History of or current cancer or lymphoma\n\n          -  Uncontrolled diabetes mellitus with elevated glycosylated hemoglobin\n\n          -  History of macrophage activation syndrome (MAS) < 3 months' duration prior to\n             screening visit\n\n          -  Inadequate hematologic, renal or liver function"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "17 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "48", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01904292", 
            "org_study_id": "WA28118"
        }, 
        "intervention": {
            "arm_group_label": "RoActemra/Actemra", 
            "description": "Subcutaneous doses weekly or every 10 days for 52 weeks", 
            "intervention_name": "tocilizumab [RoActemra/Actemra]", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "July 17, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hartford", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06106"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60649"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hackensack", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07601"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charlotte", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "28203"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27710"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229-3039"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cleveland", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44195"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84158"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98105"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina", 
                        "zip": "1270"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina", 
                        "zip": "1425"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cordoba", 
                        "country": "Argentina", 
                        "zip": "5000"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Westmead", 
                        "country": "Australia", 
                        "state": "New South Wales", 
                        "zip": "2145"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Parkville", 
                        "country": "Australia", 
                        "state": "Victoria", 
                        "zip": "3052"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Botucatu", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "18618-970"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sao Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "04023-900"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sao Paulo", 
                        "country": "Brazil", 
                        "state": "SP", 
                        "zip": "05403-000"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Calgary", 
                        "country": "Canada", 
                        "state": "Alberta", 
                        "zip": "T3B 6A8"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ottawa", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "K1H 8L1"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 1X8"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "13353"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Freiburg", 
                        "country": "Germany", 
                        "zip": "79106"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sankt Augustin", 
                        "country": "Germany", 
                        "zip": "53757"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mexico", 
                        "country": "Mexico", 
                        "zip": "06720"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miexico City", 
                        "country": "Mexico", 
                        "zip": "06700"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monterrey", 
                        "country": "Mexico", 
                        "zip": "64460"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "115522"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation", 
                        "zip": "119991"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28046"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28034"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46026"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bristol", 
                        "country": "United Kingdom", 
                        "zip": "BS2 8BJ"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liverpool", 
                        "country": "United Kingdom", 
                        "zip": "L12 2AP"
                    }
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Argentina", 
                "Australia", 
                "Brazil", 
                "Canada", 
                "Germany", 
                "Mexico", 
                "Russian Federation", 
                "Spain", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "AN PHASE Ib, OPEN-LABEL, MULTICENTER STUDY TO INVESTIGATE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF TOCILIZUMAB FOLLOWING SUBCUTANEOUS ADMINISTRATION IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS", 
        "overall_contact": {
            "email": "global.rochegenentechtrials@roche.com", 
            "last_name": "Reference Study ID Number: WA28118 www.roche.com/about_roche/roche_worldwide.htm", 
            "phone": "888-662-6728 (U.S. Only)"
        }, 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Pharmacokinetics: Area under the concentration-time curve (AUC)", 
                "safety_issue": "No", 
                "time_frame": "14 weeks"
            }, 
            {
                "measure": "Pharmacokinetics: Serum concentrations (Cmin/Cmax)", 
                "safety_issue": "No", 
                "time_frame": "14 weeks"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01904292"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Pharmacodynamics: Serum interleukin-6 (IL6)/soluble IL-6 receptor (sIL-6R) levels", 
                "safety_issue": "No", 
                "time_frame": "14 weeks"
            }, 
            {
                "measure": "Pharmacodynamics: C-reactive protein (CRP)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Pharmacodynamics: Erythrocyte sedimentation rate (ESR)", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Pharmacodynamics: Incidence of anti-TCZ antibodies", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Safety: Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "57 weeks"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}